Paper33730998
Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis.
Uchiyama K and 13 others. BMC Gastroenterol, 2021. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis. Papers, record 33730998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33730998
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis, Ulcerative | Major topic |
| Interleukin-12 | Major topic |
| Colonoscopy | |
| Humans | |
| Intestinal Mucosa | |
| Recurrence | |
| Severity of Illness Index |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9836088 | Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference. | Inflamm Bowel Dis | 1998 | https://conductscience.org/library/papers/9836088 | PubMed |
| 2 | 8700208 | Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. | Nature | 1996 | https://conductscience.org/library/papers/8700208 | PubMed |
| 3 | 28533995 | Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles. | Cureus | 2017 | https://conductscience.org/library/papers/28533995 | PubMed |
| 4 | 26741065 | Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management. | Clin Transl Gastroenterol | 2016 | https://conductscience.org/library/papers/26741065 | PubMed |
| 5 | 21723220 | Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. | Gastroenterology | 2011 | https://conductscience.org/library/papers/21723220 | PubMed |
| 6 | 23521659 | Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience. | Aliment Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23521659 | PubMed |
| 7 | 22814351 | IL-12 family cytokines: immunological playmakers. | Nat Immunol | 2012 | https://conductscience.org/library/papers/22814351 | PubMed |
| 8 | 7730613 | Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. | J Immunol | 1995 | https://conductscience.org/library/papers/7730613 | PubMed |
| 9 | 26977756 | Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study. | Am J Gastroenterol | 2016 | https://conductscience.org/library/papers/26977756 | PubMed |
| 10 | 10940279 | A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. | Gut | 2000 | https://conductscience.org/library/papers/10940279 | PubMed |
| 11 | 12563297 | Interleukin-12 and the regulation of innate resistance and adaptive immunity. | Nat Rev Immunol | 2003 | https://conductscience.org/library/papers/12563297 | PubMed |
| 12 | 30478416 | IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30478416 | PubMed |
| 13 | 19418577 | Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. | World J Gastroenterol | 2009 | https://conductscience.org/library/papers/19418577 | PubMed |
| 14 | 27959607 | Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959607 | PubMed |
| 15 | 32291786 | Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study. | Aliment Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32291786 | PubMed |
| 16 | 8196726 | Cyclosporine in severe ulcerative colitis refractory to steroid therapy. | N Engl J Med | 1994 | https://conductscience.org/library/papers/8196726 | PubMed |
| 17 | 31918598 | Mucosal gene transcription of ulcerative colitis in endoscopic remission. | Scand J Gastroenterol | 2020 | https://conductscience.org/library/papers/31918598 | PubMed |
| 18 | 25796985 | Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. | Cytokine | 2015 | https://conductscience.org/library/papers/25796985 | PubMed |
| 19 | 2504877 | Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. | J Exp Med | 1989 | https://conductscience.org/library/papers/2504877 | PubMed |
| 20 | 31553833 | Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31553833 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41064347 | Mucosal Healing of Ulcerative Colitis Based on Endoscopic Diagnosis, Histopathology, and Mucosal Inflammatory Mediators. | Inflamm Intest Dis | 2025 | https://conductscience.org/library/papers/41064347 | PubMed |
| 39474054 | A Comparative Study on the Effects of Mesenchymal Stem Cells and Their Conditioned Medium on Caco-2 Cells as an In Vitro Model for Inflammatory Bowel Disease. | Int J Cell Biol | 2024 | https://conductscience.org/library/papers/39474054 | PubMed |
| 38510687 | Cytokine and chemokine profiles in ulcerative colitis relapse after coronavirus disease 2019 vaccination. | J Clin Biochem Nutr | 2024 | https://conductscience.org/library/papers/38510687 | PubMed |
| 36698823 | Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36698823 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33730998
GET https://conductscience.org/api/papers/v1/33730998/references?page=2